|
2025
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations for use in immunology, antibodies for medica... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; An... |
|
|
G/S
|
Pharmaceutical products; vaccines. |
|
|
Invention
|
Neisseria meningitidis vaccine.
Provided herein are compounds, compositions, formulations, kits,... |
|
2024
|
Invention
|
Modified rna polymerases. This application relates to modified RNA polymerases, compositions or k... |
|
|
Invention
|
Compositions and methods for circular rna affinity purification.
The present disclosure provides... |
|
|
G/S
|
Pharmaceutical products, vaccines |
|
|
G/S
|
Pharmaceutical products, vaccines. |
|
|
G/S
|
Pharmaceutical products, vaccines. |
|
|
Invention
|
Hplc-based assays for detecting multiple mrna constructs. The disclosure relates to methods for d... |
|
|
Invention
|
Trehalose vaccine formulation. Stable liquid, lyophilized, and frozen formulations are provided f... |
|
|
Invention
|
Signal sequences for nucleic acid vaccines.
Provided herein is a nucleic acid (e.g., messenger R... |
|
|
Invention
|
Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof.
This applica... |
|
|
Invention
|
Methods for ethanol-free mrna purification.
Provided herein are methods of purifying messenger R... |
|
|
G/S
|
Pharmaceuticals; vaccines. |
|
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations for use in immunology; antibodies for medica... |
|
|
G/S
|
Pharmaceuticals; Vaccines. |
|
|
Invention
|
Meningococcal b recombinant vaccine.
The present disclosure relates to an immunogenic compositio... |
|
|
G/S
|
Pharmaceutical preparations, vaccines. |
|
|
Invention
|
Lyme disease rna vaccine.
The present disclosure provides a Lyme disease vaccine, comprising a m... |
|
|
Invention
|
Systems and devices for filtering biological products and methods of using the same. Systems and ... |
|
|
Invention
|
Human metapneumovirus viral vector-based vaccines.
The present disclosure provides a human metap... |
|
|
Invention
|
Combination respiratory mrna vaccines.
The present disclosure provides compositions comprising a... |
|
|
Invention
|
Respiratory syncytial virus vaccine and methods of use.
Disclosed herein are respiratory syncyti... |
|
|
Invention
|
Dose divider. A dose divider for releasable attachment to a plunger rod of a syringe comprises fi... |
|
|
Invention
|
Respiratory syncytial virus vaccine and methods of use. Disclosed herein are respiratory syncytia... |
|
|
Invention
|
Medicament delivery system with dose divider. A medicament delivery system comprises a syringe an... |
|
|
Invention
|
A delivery system with dose divider. A delivery system comprises a syringe having a chamber for c... |
|
|
Invention
|
Method of using a dose divider. A method of using a dose divider comprising first and second arms... |
|
|
Invention
|
Medicament delivery system with dose divider. A medicament delivery system comprises a syringe, a... |
|
|
Invention
|
Compositions for use in treatment of acne.
This invention relates to compositions (e.g. immunoge... |
|
|
Invention
|
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods... |
|
|
Invention
|
Multivalent influenza vaccines.
Disclosed are multivalent vaccine or immunogenic compositions co... |
|
|
Invention
|
Compositions and methods for rna affinity.
The present disclosure provides methods and compositi... |
|
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate composition.
Provided are mixed carrie... |
|
2023
|
Invention
|
Lipid nanoparticles for delivering mrna vaccines. Provided are novel lipid nanoparticles for deli... |
|
|
Invention
|
Lipid nanoparticles for delivering mrna vaccines.
Provided are novel lipid nanoparticles for del... |
|
|
Invention
|
Vaccines against coronaviruses |
|
|
Invention
|
Neisseria meningitidis b. Neisseria meningitidis 444 adjuvant being selected as having a point of... |
|
|
Invention
|
Adjuvanted immunogenic composition against neisseria meningitidis b |
|
|
Invention
|
Methods for ethanol-free mrna purification. Provided herein are methods of purifying messenger RN... |
|
|
Invention
|
Methods for ethanol-free mrna purification |
|
|
Invention
|
Protein-saccharide conjugation with sodium cyanoborohydride. Methods and uses of conjugating sacc... |
|
|
Invention
|
Machine-learning techniques in protein design for vaccine generation.
A discrete-data object is ... |
|
|
Invention
|
Machine-learning techniques in protein design for vaccine generation.
One or more data objects a... |
|
|
Invention
|
Machine-learning techniques in protein design for vaccine generation. A discrete-data object is r... |
|
|
Invention
|
Machine-learning techniques in protein design for vaccine generation. One or more data objects ar... |
|
|
Invention
|
Lipidic compounds, and uses thereof.
The disclosure relates to lipidic compounds of formula (I):... |
|
2022
|
Invention
|
Human metapneumovirus vaccines.
The present disclosure provides antigenic prefusion hMPV F polyp... |
|
|
Invention
|
Human metapneumovirus vaccines. The present disclosure provides antigenic prefusion hMPV F polype... |
|
|
Invention
|
Human metapneumovirus viral vector-based vaccines. The present disclosure provides a human metapn... |
|
|
Invention
|
Respiratory synctial virus rna vaccine.
The present disclosure provides a respiratory syncytial ... |
|
|
Invention
|
Methods for freezing and freeze-drying lipid nanoparticles (lnps) and lnps obtained with the same... |
|
|
Invention
|
Truncated influenza neuraminidase and methods of using the same.
Provided are modified influenza... |
|
2021
|
Invention
|
Covid-19 vaccines with tocopherol-containing squalene emulsion adjuvants.
Provided are novel vac... |
|
|
Invention
|
Vaccines against sars-cov-2 infections.
Provided are novel vaccines for prophylactic treatment o... |
|
|
Invention
|
Propionibacterium acnes prophylactic and therapeutic immune treatment.
The present invention dis... |
